Children's Healthcare IRB #1 – FDA 483, Feb 3, 2023
An FDA inspection of Children's Healthcare IRB #1 in Minneapolis revealed a significant issue regarding the composition of its Institutional Review Board (IRB) meetings. The firm was cited because its IRB did not consistently include a nonscientific member during convened meetings for non-expedited research reviews, which is a critical component for ensuring comprehensive ethical oversight. This observation indicates a potential deficiency in the IRB's review process for protecting human subjects.
ID · 599c4639-3cc5-45c1-8893-f54a45c54dce
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.